Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New guidance for purchasers of HIV/AIDS medicines

27.06.2003



An updated edition of Sources and Prices of Selected Medicines and Diagnostics for People living with HIV/AIDS will be released today. The report provides market information on 74 reviewed products for the treatment and management of HIV/AIDS from 61 manufacturers.

The report gives purchasers of AIDS medicines and diagnostics a range of choices related to suppliers and affordability. The medicines included were selected on the basis of WHO standard treatment guidelines. The list is not exhaustive but covers the most commonly used HIV/AIDS medicines, with paediatric forms included wherever possible.

Improving access to medicines for people living with HIV/AIDS is a challenge for all countries but especially for developing ones. By the end of 2002, UNAIDS estimated that 42 million people in the world were living with HIV/AIDS and that over 95% of these were in poor nations. Last year, 3.1 million people died of the disease, many of them because they had had no access to treatment.



While high prices constitute one of the main barriers to accessing treatment, a few recent initiatives have brought the price of certain medicines down. However, even where affordable alternatives exist, many decision-makers do not have the information they need to identify those manufacturers that can supply the medicines needed. Without such information, there is a risk that low-income countries pay more than necessary – and sometimes more than industrialized countries – to obtain essential medicines. The report helps fill that gap.

This report is the fourth in a series of annual publications of sources and prices surveys commenced in 1999 by United Nations Children’s Fund (UNICEF), UNAIDS, the World Health Organization (WHO) and Médecins Sans Frontières (MSF). The present edition is the result of a survey carried out from December 2002 through February 2003, of 388 manufacturers in 50 countries.

The report includes antiretroviral (ARV) medicines, medicines used to treat a range of opportunistic infections, medicines for use in palliative care, medicines for the treatment of HIV-related cancers and for the management of opioid dependence. It also provides information on a range of test kits for the diagnosis and monitoring of HIV/AIDS.

A new section has been added on the registration status of products in the survey. This information will be useful for people in countries who are in the process of granting market authorization to HIV/AIDS related products.

Finally, the latest edition of an MSF document, Untangling the Web of Price Reductions: a pricing guide for the purchase of ARVs for developing countries has been included as an annex to provide a comprehensive overview of the prices of ARV medicines offered by research-based pharmaceutical companies and some generics manufacturers in low- and middle-income countries.

Sources and Prices 2003 can be found on the following web sites: UNICEF, WHO, médecins sans frontières.

For more informations:

Ms Daniela Bagozzi
Telephone: +41 22 791 4544
Email:bagozzid@who.int

Daniela Bagozzi | WHO
Further information:
http://www.unicef.org/supply
http://www.who.int/medicines
http://www.accessmed-msf.org

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>